DSwiss Inc. reported significant financial performance improvements in its latest 10-Q filing for the six months ended June 30, 2025. The company achieved revenues of $2,022,526, a substantial increase of 92.3% compared to $1,050,744 in the same period of 2024. Gross profit also rose to $411,655 from $402,070, reflecting a gross margin of approximately 20.3%. However, net income for the six months decreased to $170,864 from $198,811 in the prior year, primarily due to increased selling, general, and administrative expenses.

The company’s total assets increased to $951,722 as of June 30, 2025, up from $635,830 at the end of 2024. This growth was driven by a rise in cash and cash equivalents, which reached $580,951, compared to $397,476 at the end of the previous fiscal year. DSwiss also reported a decrease in accumulated deficit to $1,217,066 from $1,387,930, indicating improved financial health. The company’s liabilities increased to $701,647, up from $561,794, largely due to higher accounts payable and finance lease liabilities.

In terms of operational developments, DSwiss has expanded its product offerings and geographic reach, particularly in the ASEAN region. The company continues to focus on its core business of biotech-nutraceuticals and beauty supplies, leveraging its manufacturing capabilities to provide OEM/ODM services. The number of shares outstanding remained stable at 206,904,585, and the company has maintained its status as a smaller reporting company. DSwiss has also made strategic investments, including acquiring a 60% interest in DSwiss Biotech Sdn Bhd, enhancing its research and development capabilities.

Looking ahead, DSwiss plans to enhance its marketing strategies, particularly through social media, to drive customer engagement and brand awareness. The company aims to expand its operations globally by forming partnerships with local companies in various countries. However, management has expressed concerns regarding its ability to continue as a going concern, citing the need for improved profitability and potential reliance on shareholder support for future financing. The company is actively working to address these challenges while continuing to invest in product development and market expansion.

About DSwiss Inc

DSwiss, Inc. is a biotech nutraceutical company specializing in high-quality health, skincare, and personal care products. It offers OEM/ODM manufacturing, functional foods, supplements, and natural remedies, serving markets across Asia and globally. Focused on innovation, quality, and regulatory compliance, it leverages advanced R&D, strategic partnerships, and digital marketing to deliver customized solutions and expand its global presence in health and beauty industries.

This description was generated via AI from an annual report. Updated 8 months ago.

About 10-Q Filings

A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.

Key points about the 10-Q:

  • Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
  • Content: It includes:
    • Financial statements showing the company's current financial position
    • Updates from management on the performance and projections of the business
    • Information about potential risks the company faces
    • Details on how the company is run internally
  • Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.

Our Methodology

AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.

Our method:

  1. Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
  2. AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
  3. Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
  4. Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
  5. Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Read more about AssetRoom

Feedback & Corrections

Spot an error or have a suggestion? Contact us.